Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Authors
Keywords
-
Journal
GUT
Volume 65, Issue 7, Pages 1202-1214
Publisher
BMJ
Online
2016-02-15
DOI
10.1136/gutjnl-2015-310798
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fatty acids from fat cell lipolysis do not activate an inflammatory response but are stored as triacylglycerols in adipose tissue macrophages
- (2015) Sylvie Caspar-Bauguil et al. DIABETOLOGIA
- Phosphorylation of the nuclear receptor corepressor 1 by protein kinase B switches its corepressor targets in the liver in mice
- (2015) Young Suk Jo et al. HEPATOLOGY
- Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21
- (2015) Peipei Lu et al. HEPATOLOGY
- Fasting-induced G0/G1 switch gene 2 and FGF21 expression in the liver are under regulation of adipose tissue derived fatty acids
- (2015) Doris Jaeger et al. JOURNAL OF HEPATOLOGY
- PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
- (2015) Sven Francque et al. JOURNAL OF HEPATOLOGY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet
- (2014) Naoki Tanaka et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Role of adipose tissue in methionine–choline-deficient model of non-alcoholic steatohepatitis (NASH)
- (2014) Pooja Jha et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
- (2014) K. R. Markan et al. DIABETES
- Liver-Enriched Transcription Factor CREBH Interacts With Peroxisome Proliferator-Activated Receptor α to Regulate Metabolic Hormone FGF21
- (2014) Hyunbae Kim et al. ENDOCRINOLOGY
- New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease
- (2014) Amirhossein Sahebkar et al. EXPERT OPINION ON PHARMACOTHERAPY
- Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets
- (2014) Ffolliott M. Fisher et al. GASTROENTEROLOGY
- Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia
- (2014) David G. Cotter et al. JOURNAL OF CLINICAL INVESTIGATION
- Inventing new medicines: The FGF21 story
- (2014) Alexei Kharitonenkov et al. Molecular Metabolism
- Integrated physiology and systems biology of PPARα
- (2014) Sander Kersten Molecular Metabolism
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia
- (2013) Pooja Jha et al. HEPATOLOGY
- A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use
- (2013) Sihao Liu et al. NATURE
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
- (2013) Alexander Wree et al. Nature Reviews Gastroenterology & Hepatology
- Altered Lipid Metabolism in Residual White Adipose Tissues of Bscl2 Deficient Mice
- (2013) Weiqin Chen et al. PLoS One
- Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation
- (2012) Ana Luísa De Sousa-Coelho et al. BIOCHEMICAL JOURNAL
- PPARs at the crossroads of lipid signaling and inflammation
- (2012) Walter Wahli et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes
- (2011) Tsuyoshi Goto et al. JOURNAL OF LIPID RESEARCH
- PPARα Expression Protects Male Mice from High Fat–Induced Nonalcoholic Fatty Liver
- (2011) Mohamed A. Abdelmegeed et al. JOURNAL OF NUTRITION
- Liver X receptor negatively regulates fibroblast growth factor 21 in the fatty liver induced by cholesterol-enriched diet
- (2011) Takashi Uebanso et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
- (2011) Guenter Haemmerle et al. NATURE MEDICINE
- Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver
- (2009) Manu V. Chakravarthy et al. CELL
- Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes
- (2009) Katsumi Iizuka et al. FEBS LETTERS
- Peroxisome Proliferator-Activated Receptor / (PPAR / ) but Not PPAR Serves as a Plasma Free Fatty Acid Sensor in Liver
- (2009) L. M. Sanderson et al. MOLECULAR AND CELLULAR BIOLOGY
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
- (2008) Catherine Postic et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started